• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同疾病状态下的纤溶酶原激活物抑制剂1和纤溶酶原激活物抑制剂2

Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states.

作者信息

Kruithof E K, Gudinchet A, Bachmann F

机构信息

Department of Medicine, University Hospital Center, CHUV, Lausanne, Switzerland.

出版信息

Thromb Haemost. 1988 Feb 25;59(1):7-12.

PMID:3129809
Abstract

The association of increased PA-inhibitor (PAI) activity and of PAI-1 and PAI-2 antigen levels with different pathological conditions was studied in a collective of over 300 patients. PAI-1 and PAI-2 levels were measured by specific radioimmunoassays. A good correlation was observed of PAI activity with PAI-1 antigen (r = 0.718; p less than 0.0001) but not with PAI-2 (r = 0.070; n.s.). Both in the controls and in the patients, PAI activity and PAI-1 antigen showed an extremely large range of values. PAI activity ranged from 0.5 to 68 U/ml and PAI-1 antigen from 6 to 600 ng/ml. Increased PAI activity and PAI-1 antigen was observed in patients with malignant tumors, cardiovascular or thromboembolic disease, in the postoperative phase, with hepatic insufficiency, after trauma and after extracorporeal circulation. The large spectrum of disease states with increased PAI activity and PAI-1 antigen reinforces previous suggestions that PAI-1 is an acute phase reactant. After extracorporeal circulation, PAI activity and PAI-1 concentrations strongly increased within one hour, remained elevated for at least one week and returned to preoperation values within 7 days. PAI-2 values ranged from below detection limit (15 ng/ml), observed in half of the plasmas, to 485 ng/ml in a pregnant woman. High values of PAI-2 were only observed in pregnancy.

摘要

在300多名患者群体中研究了纤溶酶原激活物抑制剂(PAI)活性增加以及PAI-1和PAI-2抗原水平与不同病理状况之间的关联。通过特异性放射免疫测定法测量PAI-1和PAI-2水平。观察到PAI活性与PAI-1抗原之间具有良好的相关性(r = 0.718;p < 0.0001),但与PAI-2无相关性(r = 0.070;无显著性差异)。在对照组和患者中,PAI活性和PAI-1抗原均显示出极大的数值范围。PAI活性范围为0.5至68 U/ml,PAI-1抗原范围为6至600 ng/ml。在患有恶性肿瘤、心血管或血栓栓塞性疾病的患者、术后阶段、肝功能不全患者、创伤后以及体外循环后的患者中观察到PAI活性和PAI-1抗原增加。PAI活性和PAI-1抗原增加的疾病状态范围广泛,这进一步支持了之前关于PAI-1是一种急性期反应物的观点。体外循环后,PAI活性和PAI-1浓度在1小时内强烈升高,至少持续1周升高,然后在7天内恢复到术前值。PAI-2值范围从在一半血浆中观察到的低于检测限(15 ng/ml)到一名孕妇中的485 ng/ml。仅在妊娠期间观察到PAI-2的高值。

相似文献

1
Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states.不同疾病状态下的纤溶酶原激活物抑制剂1和纤溶酶原激活物抑制剂2
Thromb Haemost. 1988 Feb 25;59(1):7-12.
2
Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
Thromb Haemost. 1989 Sep 29;62(2):651-3.
3
Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.孕期羊水中的1型和2型纤溶酶原激活物抑制剂及纤溶酶原激活物
Thromb Haemost. 1990 Oct 22;64(2):281-5.
4
Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.U-937单核吞噬细胞对尿激酶型纤溶酶原激活剂和纤溶酶原激活剂抑制剂-2表达的调节作用。1α,25-二羟基维生素D3和佛波酯的影响。
J Immunol. 1988 Oct 15;141(8):2693-8.
5
Plasminogen activator inhibitor activity in bacterial infection.细菌感染中的纤溶酶原激活物抑制剂活性
Thromb Haemost. 1988 Jun 16;59(3):451-4.
6
Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.不稳定型冠状动脉疾病和急性心肌梗死患者血浆中纤溶酶原激活物抑制剂和组织纤溶酶原激活物水平的昼夜波动。
Thromb Haemost. 1988 Dec 22;60(3):372-6.
7
Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.正常受试者的纤维蛋白溶解——纤溶酶原激活物抑制剂与纤维蛋白溶解系统其他成分的比较
Thromb Haemost. 1988 Apr 8;59(2):299-303.
8
Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease.冠心病男性患者体内的纤溶酶原激活物及纤溶酶原激活物抑制剂活性
J Lab Clin Med. 1989 Jan;113(1):88-93.
9
Increased plasminogen activator inhibition levels in malignancy.恶性肿瘤中纤溶酶原激活物抑制水平升高。
Thromb Haemost. 1987 Apr 7;57(2):140-3.
10
Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).组织型纤溶酶原激活物(t-PA)及其快速作用抑制剂(PAI-1)血液中的日间波动。
Thromb Haemost. 1988 Apr 8;59(2):329-32.

引用本文的文献

1
Diagnostic Power of Circulatory Metabolic Biomarkers as Metabolic Syndrome Risk Predictors in Community-Dwelling Older Adults in Northwest of England (A Feasibility Study).循环代谢生物标志物作为英国西北部社区居住的老年人群代谢综合征风险预测因子的诊断能力(一项可行性研究)。
Nutrients. 2021 Jun 30;13(7):2275. doi: 10.3390/nu13072275.
2
Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis.2型糖尿病蛋白与新冠病毒生物标志物的映射关系:蛋白质组学分析
Metabol Open. 2020 Dec 13;9:100074. doi: 10.1016/j.metop.2020.100074. eCollection 2021 Mar.
3
Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects.
纤溶酶原激活物抑制剂-1水平与肥胖非糖尿病受试者的脂蛋白亚组分相关。
Int J Endocrinol. 2018 May 30;2018:9596054. doi: 10.1155/2018/9596054. eCollection 2018.
4
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population.代谢综合征生物标志物的系统评价:西弗吉尼亚州人群早期检测、管理及风险分层的指标体系
Int J Med Sci. 2016 Jan 1;13(1):25-38. doi: 10.7150/ijms.13800. eCollection 2016.
5
p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure.p53 和 PAI-1 介导的 C-X-C 趋化因子及其受体 CXCR2 的诱导:在香烟烟雾暴露导致的肺部炎症中的重要性。
Am J Physiol Lung Cell Mol Physiol. 2016 Mar 15;310(6):L496-506. doi: 10.1152/ajplung.00290.2015. Epub 2016 Jan 8.
6
Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.C1抑制剂水平正常的遗传性血管性水肿患者血浆中纤溶酶原激活物抑制剂2缺乏
J Allergy Clin Immunol. 2016 Jun;137(6):1822-1829.e1. doi: 10.1016/j.jaci.2015.07.041. Epub 2015 Sep 26.
7
Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induced lung injury.纤溶酶原激活物抑制剂-1在香烟烟雾暴露和甲型流感病毒感染诱导的肺损伤中的作用
PLoS One. 2015 May 1;10(5):e0123187. doi: 10.1371/journal.pone.0123187. eCollection 2015.
8
Effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma in plasminogen activator inhibitor-1 deficient and wild-type mice.高脂饮食对纤溶酶原激活物抑制剂-1缺陷型和野生型小鼠Lewis肺癌自发转移的影响。
PLoS One. 2014 Oct 30;9(10):e110869. doi: 10.1371/journal.pone.0110869. eCollection 2014.
9
Twenty-four-hour venoarterial extracorporeal membrane oxygenation without systemic heparinization in dogs.
Pediatr Surg Int. 1996 Aug;11(7):466-70. doi: 10.1007/BF00180084. Epub 2013 Sep 21.
10
Regulation of airway and alveolar epithelial cell apoptosis by p53-Induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury.烟雾暴露损伤中 p53 诱导的纤溶酶原激活物抑制剂-1 对气道和肺泡上皮细胞凋亡的调节。
Am J Respir Cell Mol Biol. 2012 Oct;47(4):474-83. doi: 10.1165/rcmb.2011-0390OC. Epub 2012 May 16.